Table 1.
Characteristics of HBsAg-positive and HBsAg-negative subjects in Changhai Hospital (n=428)
| Characteristics, n (%) | HBV (-), n = 335 (78.3%) | HBV (+), n = 93 (21.7%) | P-value |
|---|---|---|---|
| Gender | 0.017 | ||
| Male | 188 (56.1%) | 65 (69.9%) | |
| Female | 147 (43.9%) | 28 (30.1%) | |
| Median age | 55.0 | 47.0 | 0.032 |
| Stage | 0.014 | ||
| I+II | 130 (38.8%) | 23 (24.7%) | |
| III+IV | 205 (61.2%) | 70 (75.3%) | |
| Cell of origin | 0.598 | ||
| Non-GCB | 190 (56.7%) | 57 (61.3%) | |
| GCB | 97 (29.0%) | 25 (26.9%) | |
| Not available | 48 (14.3%) | 11 (11.8%) | |
| Liver function | 0.002 | ||
| Normal | 320 (95.5%) | 79 (84.9%) | |
| Abnormal | 15 (4.5%) | 14 (15.1%) | |
| LDH | 0.082 | ||
| Normal | 231 (69.0%) | 55 (59.1%) | |
| Elevated | 104 (31.0%) | 38 (40.9%) | |
| Median Ki67 expression | 71.85% | 70.00% | 0.833 |
| Chemotherapy outcome | 0.028 | ||
| CR+PR | 246 (73.4%) | 57 (61.3%) | |
| Relapse+NR | 89 (26.6%) | 36 (38.7%) | |
| Rituximab included | 0.069 | ||
| No | 118 (35.2%) | 43 (46.2%) | |
| Yes | 217 (64.8%) | 50 (53.8%) |